|
| Press Releases |
|
 |
|
| Wednesday, August 3, 2022 |
|
|
Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002 |
| Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or "the Company", SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research and development more info >> |
|
| Monday, November 15, 2021 |
|
|
兆科眼科获选于2021年美国眼科学会年会Eyecelerator@AAO上发表演讲 |
| 致力于眼科疗法的研究、开发及商业化，以满足巨大医疗需求缺口的领先眼科制药企业兆科眼科有限公司（「兆科眼科」；香港联交所股份代号：6622）获选于2021年11月11日在美国新奥尔良举行的2021年美国眼科学会年会Eyecelerator@AAO上发表演讲。 more info >> |
|
|
兆科眼科獲選於2021年美國眼科學會年會Eyecelerator@AAO上發表演講 |
| 致力於眼科療法的研究、開發及商業化，以滿足巨大醫療需求缺口的領先眼科製藥企業兆科眼科有限公司（「兆科眼科」；香港聯交所股份代號：6622）獲選於2021年11月11日在美國新奧爾良舉行的2021年美國眼科學會年會Eyecelerator@AAO上發表演講。 more info >> |
|
| Monday, May 24, 2021 |
|
|
兆科眼科(6622.HK)两项产品通过国家药监局药品注册现场核查及GMP符合性检查 |
| 致力于眼科疗法的研究、开发及商业化的眼科制药公司——兆科眼科有限公司(「兆科眼科」或「公司」；股份代号：6622)，宣布两项药品——贝美素噻吗洛尔滴眼液(在中国用于治疗青光眼的潜在首仿药 more info >> |
|
|
兆科眼科(6622.HK)兩項產品通過國家藥監局藥品註冊現場核查及GMP符合性檢查 |
| 致力於眼科療法的研究、開發及商業化的眼科製藥公司——兆科眼科有限公司(「兆科眼科」或「公司」；股份代號：6622)，宣佈兩項藥品——貝美素噻嗎洛爾滴眼液(在中國用於治療青光眼的潛在首仿藥 more info >> |
|
|
Two Products of Zhaoke Ophthalmology (6622.HK) Passes On-Site Inspection for Drug Registration by National Medical Products Administration and GMP Compliance Inspection by Guangdong Medical Products Administration |
| Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or the "Company"; stock code: 6622), an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
エーザイとバイオジェン・インク、早期アルツハイマー病治療剤「レケンビ(R)」の皮下注射製剤維持投与に関する 生物製剤承認申請を米国FDAが受理
Jan 14, 2025 10:00: JST
|
|
|
Investing in Tomorrow: Winvest Group Opens Up Metaverse Opportunities
Jan 13, 2025 23:00: JST
|
|
|
Investing in Tomorrow: Winvest Group Opens Up Metaverse Opportunities
Jan 13, 2025 23:00 HKT/SGT
|
|
|
18th Asian Financial Forum officially kicks off today
Jan 13, 2025 23:00 HKT/SGT
|
|
|
聯控旗下君聯資本投資企業布魯可於港交所成功上市
Jan 13, 2025 23:00 HKT/SGT
|
|
|
「中國房車第一股」新吉奧房車港股上市：領航全球房車市場新風
Jan 13, 2025 22:55 HKT/SGT
|
|
|
Microware and GAREA TECH collaborate to focus on the digital transformation of primary healthcare in Hong Kong
Jan 13, 2025 22:50 HKT/SGT
|
|
|
AI and Big Data Expo Global Countdown: Less than 4 weeks to go!
Jan 13, 2025 22:36 HKT/SGT
|
|
|
Move Digital CEO Kristof Schoffling Leads AI Revolution in 2025
Jan 13, 2025 22:00: JST
|
|
|
Move Digital CEO Kristof Schoffling Leads AI Revolution in 2025
Jan 13, 2025 21:00 HKT/SGT
|
|
|
联控旗下君联资本投资企业布鲁可于港交所成功上市
Jan 13, 2025 19:21 HKT/SGT
|
|
|
「中国房车第一股」新吉奥房车港股上市：领航全球房车市场新风
Jan 13, 2025 18:51 HKT/SGT
|
|
|
Honda Civic Hybrid Named 2025 North American Car of the Year, Making Civic the Most Honored Model in the History of the Award
Jan 13, 2025 17:07 JST
|
|
|
Driving Digital Change: The 33rd Digital Transformation Summit to Shape India's $1 Trillion Digital Market
Jan 13, 2025 11:24 HKT/SGT
|
|
|
Swiss WEB3FEST Winter Edition 2025
Jan 13, 2025 08:01 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
